PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Recently Added NEW Latest cases added to the library
AUTH/3282/11/19
Gilead Sciences Europe
Social Media & Digital · 2019
▶ Video 🎧 Podcast
AUTH/2991/11/17
Pfizer
Samples & Gifts · 2015
▶ Video 🎧 Podcast
AUTH/2082/1/08
Recordati Pharmaceuticals
Promotional Material · 2019
▶ Video 🎧 Podcast
AUTH/2079/1/08
Gamble Pharmaceuticals UK
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2102/2/08
Meda Pharmaceuticals
Transfers of Value · 2008
▶ Video 🎧 Podcast
AUTH/2149/7/08
Syner-Med
Promotional Material · 2008
▶ Video 🎧 Podcast
AUTH/2428/8/11
AstraZeneca
Scientific Information · 2008
▶ Video 🎧 Podcast
AUTH/1899/10/06
AstraZeneca
Samples & Gifts · 2019
▶ Video 🎧 Podcast
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 189 results · Cardiovascular  · Clear
🔒 Subscribers only
AUTH/3889/4/24
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bayer
An anonymous, contactable complainant challenged a promotional email for Xarelto (rivaroxaban) sent by a third party on Bayer’s behalf to verified UK general practitioners.The complainant alleged…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3744/2/23
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim
A promotional webpage on a third-party hosted site (“Chronic Conditions”) included a single-click link to prescribing information (PI) for Pradaxa and Praxbind.The PI link stopped working from …
Clauses: 4.3
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3727/1/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Janssen
A UK cardiologist complained about a Janssen-hosted video of a Janssen-sponsored PAH symposium (“Connect, confirm, combine in pulmonary arterial hypertension”) on a Janssen website for UK healt…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3725/1/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Clauses 2, 5.1 and 12.1 after outdated Entresto prescribing information appeared i
An anonymous health professional complained about Entresto (sacubitril/valsartan) prescribing information (PI) on Novartis’ UK HCP portal. Two downloadable documents contained older PI than the…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3793/7/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant alleged two articles on a charitable organisation’s website were disease awareness pieces funded by Daiichi Sankyo, with sponsorship only apparent at the end of the artic…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3772/6/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A contactable complainant challenged a promotional email for Nustendi (bempedoic acid + ezetimibe) sent via a third-party publisher. The email prominently urged: “Switch ezetimibe to Nustendi to …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3778/6/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An article titled ‘Exploring the potential of remote atrial fibrillation diagnosis through digital technology’ was published in Cardiac Rhythm News (August 2021).The opportunity arose after Dai…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3770/5/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant alleged that a Nilemdo/Nustendi promotional website suggested Nustendi could be added to statins without stating a key contraindication from the Nustendi SmPC.The contraind…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3816/7/23
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Stirling Anglian breached Clause 12.9 after omitting adverse event reporting statement from Acepiro
An anonymous, non-contactable complainant queried a digital banner advertisement for Acepiro (acetylcysteine) on a learned society’s website, noting the absence of a “safety statement” in the…
Clauses: 12.9
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3836/10/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
GSK breached ABPI Code over Zejula AE management webpage that omitted discontinuation scenarios
An anonymous, contactable health professional complained about a GSK promotional webpage for Zejula (niraparib) on the GSKPro site, titled “PRIMA AE management”.The webpage stated: “If your p…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3776/6/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous, contactable complainant challenged a guideline document (“Interactive Lipid Management Pathway”) hosted in a patient organisation’s HCP-facing “Tackling Cholesterol Together�…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3677/7/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous, contactable health professional complained about promotion of Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe). Concern: representatives used sales aids and hard-copy …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3615/3/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached Code over uncertified mobile ‘final form’ differences on Lixiana HCP and pat
An anonymous, contactable complainant alleged Daiichi Sankyo had not properly certified mobile versions of Lixiana (edoxaban) webpages. On the HCP promotional site (lixiana-hcp.co.uk), the desktop …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3595/1/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bristol Myers Squibb & Pfizer
A GP complainant challenged four patient information booklets hosted in the “patient materials” section of the Eliquis (apixaban) website, alleging they were not updated to reflect multiple SPC…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3611/2/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A health professional complained about an electronic NICE technology appraisal (TA694) summary card for Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe), commissioned and funded by …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3612/2/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached Code over statin contraindication clarity and PI display time in live sympos
A health professional complained about a Daiichi Sankyo promotional symposium (live and later on-demand) for Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe) at a learned society vi…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3630/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant (ex-employee) challenged the mobile view of Daiichi Sankyo’s promotional Lixiana (edoxaban) HCP website (ref EDX/22/0052, date of preparation March 2022). The complainant…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3626/3/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis
An anonymous health professional complained about four articles in an online supplement: “2021, Volume 28, Supplement 2: Inclisiran▼ – its clinical position in lipid management”, initiated …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3629/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo disease awareness campaign with patient organisation
An anonymous whistleblowing complainant alleged Daiichi Sankyo initiated and conducted a “get a cholesterol test” disease awareness campaign with a patient organisation and that not all related…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3632/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A cardiac expert complained about what was described as a webinar/video on initiating Lixiana (edoxaban) hosted on a learned society webpage.The complainant alleged the video focused on renal funct…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3634/4/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A cardiac specialist complained about a Daiichi Sankyo promotional leavepiece for UK prescribers on how to initiate Lixiana (edoxaban) (EDX/22/0161; date of preparation March 2022).The complainant …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3642/5/22
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached Clause 4.9 after Entresto sponsored BJC supplement articles omitted adverse event
An anonymous, contactable complainant (self-described cardiac specialist) complained about five Novartis-initiated and funded promotional articles/supplements about Entresto (sacubitril/valsartan) …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3627/4/22
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo breached the ABPI Code over Lixiana patient booklets that omitted key bleeding warnin
A health professional complained about two Daiichi Sankyo patient booklets for Lixiana (edoxaban): Understanding your treatment for atrial fibrillation (EDX/21/0229, March 2021) and Understanding y…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3633/4/22
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis breached the ABPI Code after Entresto HCP website omitted key hepatic/renal safety details
An anonymous cardiac specialist complained about a Novartis UK health professional promotional webpage for Entresto (sacubitril/valsartan): “Starting and monitoring Entresto” (ref 145885, Octob…
Clauses: NONE
2022 🔒 Subscribe
1 2 3 4 Next → Page 1 of 8 — 189 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews